Dr. Graham S. Ingalsbe, MD

Dr. Ingalsbe practices at Northern Nevada Sierra Medical Center in Reno, Nevada.

Dr. Ingalsbe's NPI, 1013259431, was assigned on March 24, 2013. Dr. Ingalsbe graduated from University of Miami, Lm Miller School of Medicine in 2013. Dr. Ingalsbe holds Nevada license 16809.

Dr. Ingalsbe's primary practice is Northern Nevada Sierra Medical Center, at 625 Innovation Dr, Reno, NV 89511 in Washoe County. The practice phone is (775) 799-7320.

Dr. Ingalsbe's primary practice is Northern Nevada Sierra Medical Center in Reno, Nevada. Dr. Ingalsbe is also affiliated with Denver Health Medical Center. The medical group on file is Sound Physicians. Dmand AI also links Dr. Ingalsbe to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingalsbe practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Ingalsbe's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Ingalsbe is licensed in Nevada.

CMS data shows 276 Medicare services from Dr. Ingalsbe across 4 procedure codes in 2024, for 264 Medicare patients. Medicare paid $30,116 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 264 Medicare patients who saw Dr. Ingalsbe in 2024. The largest group is 75 to 84, with 108 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ingalsbe's median patient age at 59, with 55% women.

In 2024, Dr. Ingalsbe wrote 285 Medicare Part D claims for 184 patients. 93% of them were for generic drugs. CMS names the drug for 161 of them, across 9 drugs with 11 or more claims each, at $1,417 in total drug cost. In 2023, CMS named 162 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ingalsbe for performance year 2024, reported as part of a group. Dr. Ingalsbe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Ingalsbe from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $15.

Dr. Ingalsbe graduated from University of Miami, Lm Miller School of Medicine in 2013.